MEDANTA · Global Health Limited · Financials
Market Cap
390.94B INR
Shares
268.87M
Volume · Nov 13
128.42K
Avg daily vol (3M)
275.53K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
44.1B
+19.4%
FY2026
Net Income
5.56B
+15.6%
FY2026
Operating Cash Flow
7.14B
+14.5%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| INR | 50.53B | 44.1B | 36.92B | 32.75B | 26.94B |
| INR | 2.67B | 2.23B | 1.94B | 1.73B | 1.5B |
| INR | 1.03B | 791.14M | 652.59M | 739.13M | 779.19M |
| INR | 8.15B | 7.15B | 6.47B | 6.27B | 4.49B |
| INR | 2.02B | 1.61B | 1.66B | 1.49B | 1.23B |
| INR | 3.98B | 5.56B | 4.81B | 4.78B | 3.26B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2026: 134.4M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.